Resource Type: Expert Article

Indero Showcasing Dermatology Expertise at EADV Congress in Paris

Indero is proud to highlight the contributions of its team at the 2025 EADV Congress in Paris, one of the leading global events in dermatology research and innovation. Late-Breaking Presentation On September 18th, Dr. Robert Bissonnette, Founder and Executive Chairman of Indero, presented a late-breaking session titled: “Safety of Delgocitinib Cream in Adult Patients with Chronic […]

EADV 2025’s Sessions You Cannot Miss

  The European Academy of Dermatology and Venereology (EADV) Congress 2025, held at the Paris Convention Centre from 17 to 20 September, is set to be a powerhouse of innovation, clinical insight, and scientific exchange. With over 180 sessions, 600+ speakers, and attendees, this year’s program offers a unique opportunity to stay ahead of scientific […]

Q&A: Strategies for Successful Global Clinical Trial Delivery

In this Q&A, Randa Wahid of Indero, and Lyn Mursalo, a freelance clinical research professional, share how sponsors and CROs can build collaborative partnerships, navigate global trial complexities, and apply practical strategies to deliver studies on time and with quality. Read More

Measuring Success: Navigating the Top 3 Clinical Outcome Assessments in Hidradenitis Suppurativa

In clinical research, particularly in the study of hidradenitis suppurativa (HS), the evaluation of treatment efficacy is of paramount importance. This article provides a comprehensive overview of the 3 most commonly used clinical outcome assessments (COAs) in HS trials: the HS Clinical Response (HiSCR), the HS Quality of Life (HiSQOL), and the Hurley Stages of […]

Delayed Payments, Diminished Performance: The Site Perspective

Delayed payments and financial holdbacks from sponsors and CROs are placing increasing strain on clinical trial sites, threatening their operational stability and performance. Contributing their expert insights are Ted Trafford, a veteran executive who has spent nearly 30 years at Probity Medical Research building a global network of over 70 investigative sites across multiple therapeutic areas, and Brad […]

Measuring Success: Navigating the Top 3 Clinical Outcome Assessments in Alopecia Areata

Alopecia areata (AA) is a multifaceted condition that presents unique challenges for both clinicians and patients. The precise evaluation of treatment results is pivotal in ascertaining the process of various therapeutic strategies. This article explores 3 key clinical outcome assessments (COAs) used in AA: the Severity of Alopecia Tool (SALT), the AA Investigator Global Assessment […]

Strengthening Sponsor–Site Partnerships in Clinical Research: Keys to Sustained Site Motivation and Operational Success

Successful collaboration between sponsors, CROs, and clinical trial sites is a cornerstone of efficient and high-quality clinical research. This article explores the key dos and don’ts for fostering productive site partnerships, with a focus on sustaining investigator motivation and study momentum. Contributing their expert insights are Ted Trafford, a veteran executive who has spent nearly 30 […]

Building Trust and Long-Term Relationships in Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

Trust and long-term relationships are essential for the success of clinical trials. Building and maintaining these relationships between sponsors, CROs, and sites ensures smooth trial execution and high-quality outcomes. This article explores strategies for building trust and fostering long-term relationships in clinical trials, with a focus on what biotech, and pharmaceutical sponsors need to know.  […]

Accelerating Study Start-Up and Contract Negotiations in Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

The efficiency of study start-up and contract negotiations can significantly impact the success of clinical trials. Streamlining these processes ensures that trials commence on time and run smoothly. This article explores best practices for accelerating study start-up and contract negotiations, with a focus on what biotech, and pharmaceutical companies need to know.  Streamlining Contract Negotiations  […]

Reframing Process Improvement in Clinical Trials

Guillaume Gigon, VP of Technology and AI, and Robert Taylor, Associate Director, Clinical Operations at Indero, explore how Lean Six Sigma (LSS) principles – minimising waste, standardising workflows, and driving improvement through data – are being adapted from manufacturing industries to deliver clinical trials faster, more efficiently, and with greater consistency. Read More